Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets
about
Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates.Evaluation of replication and cross-reactive antibody responses of H2 subtype influenza viruses in mice and ferrets.Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets.Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.Evaluation of replication, immunogenicity and protective efficacy of a live attenuated cold-adapted pandemic H1N1 influenza virus vaccine in non-human primatesThe magnitude of local immunity in the lungs of mice induced by live attenuated influenza vaccines is determined by local viral replication and induction of cytokinesDevelopment of a mouse-adapted live attenuated influenza virus that permits in vivo analysis of enhancements to the safety of live attenuated influenza virus vaccine.Systems biology of vaccination for seasonal influenza in humans.A live attenuated vaccine prevents replication and transmission of H7N9 virus in mammals.The contribution of systemic and pulmonary immune effectors to vaccine-induced protection from H5N1 influenza virus infection.Potency of an inactivated influenza vaccine prepared from A/duck/Hokkaido/162/2013 (H2N1) against a challenge with A/swine/Missouri/2124514/2006 (H2N3) in mice.Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells.
P2860
Q30206089-2A9138A7-5ADF-4DE2-A594-EDCC4CAB2D9DQ30227151-9558AFB5-5C96-4D48-A0ED-E52A6F9CFFB0Q30357270-9BBD7615-3B04-43AF-AD35-41099CB5FD0DQ30365079-D9184EF6-ED08-4400-9586-1478BEFB2E45Q30395088-EC7774C2-74A4-4056-BECE-D0C4ABFD9E5FQ30414282-063198BB-263B-4C4A-908A-2EA4B7EBABD7Q30419112-E6FEB248-A3A5-44E0-AD0C-E7AF41BB0556Q34458066-708610C2-7AC7-49E6-8A79-9B2CD3462B73Q35110968-54652636-57C2-4F65-B2EE-8AB6C7B65FA5Q35118722-0DB59F8E-1530-49B7-9E8F-90827C36AD2AQ35710438-53126C73-1493-4241-9F90-ADDD6F92FF63Q35943771-2537892E-761D-459D-B694-51FE038CE538Q41921267-828B72FE-96E0-4B25-B13C-BD47744057BBQ41926883-31891F1D-F1C5-4793-A25F-D319965E0F37
P2860
Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Safety, immunogencity, and eff ...... 2) vaccine in mice and ferrets
@ast
Safety, immunogencity, and eff ...... 2) vaccine in mice and ferrets
@en
type
label
Safety, immunogencity, and eff ...... 2) vaccine in mice and ferrets
@ast
Safety, immunogencity, and eff ...... 2) vaccine in mice and ferrets
@en
prefLabel
Safety, immunogencity, and eff ...... 2) vaccine in mice and ferrets
@ast
Safety, immunogencity, and eff ...... 2) vaccine in mice and ferrets
@en
P2860
P50
P1433
P1476
Safety, immunogencity, and eff ...... 2) vaccine in mice and ferrets
@en
P2093
Elaine W Lamirande
Grace L Chen
P2860
P304
P356
10.1016/J.VIROL.2009.12.003
P407
P577
2009-12-24T00:00:00Z